-
Á¤¿õ±â
º´¿øÀå
(ÀÇÇйڻç, ¹æ»ç¼±Á¾¾çÇаú Àü¹®ÀÇ)
-
¹æ»ç¼±Á¾¾çÇÐ (µÎ°æºÎ¾Ï, ³úÁ¾¾ç, ¸²ÇÁÁ¾)
-
- ¤ý1973.3 ~1979.2
- Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇлç
- ¤ý1979.3 ~1983.2
- Àü³²´ëÇб³º´¿ø ÀÎÅÏ ¹× ¹æ»ç¼±°ú Àü°øÀÇ °úÁ¤ ¼ö·á
- ¤ý1980.3 ~1982.2
- Àü³²´ëÇб³ ´ëÇпø ÀÇÇÐ ¼®»ç
- ¤ý1991.8
- Àü³²´ëÇб³ ´ëÇпø ÀÇÇÐ ¹Ú»ç ÇÐÀ§ Ãëµæ
-
-
-
- ¤ý1983.4 ~ 1986.4
- °øÁߺ¸°ÇÀÇ»ç
- ¤ý1986.5 ~ 1988.2
- ¾Æ»êº¹ÁöÀç´Ü º¸¼ºº´¿ø ¹æ»ç¼±°úÀå
- ¤ý1988.3 ~ 1989.8
- ¼¿ï´ëÇб³º´¿ø ¹æ»ç¼±Á¾¾çÇаú ÀüÀÓÀÇ»ç
- ¤ý1989.9 ~ ÇöÀç
- Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç, ±³¼ö
- ¤ý1999.3 ~ 2005.3
- Àü³²´ëÇб³º´¿ø ¹æ»ç¼±Á¾¾çÇаúÀå
- ¤ý2002.6 ~ 2008.6
- Àü³²´ëÇб³º´¿ø Çи¶À»ºÀ»çȸ ºÎȸÀå
- ¤ý2003.3 ~ 2013.2
- Àü³²ÀÇ´ë ¹æ»ç¼±Á¾¾çÇб³½Ç ÁÖÀÓ±³¼ö
- ¤ý2004.4 ~ 2006.4
- ȼøÀü³²´ëÇб³º´¿ø ¹æ»ç¼±Á¾¾çÇаúÀå
- ¤ý2006.10 ~ 2008.10
- ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ºÎȸÀå
- ¤ý2007.3 ~ 2008.3
- Àü³²´ëÇб³º´¿ø È«º¸½ÇÀå
- ¤ý2013.12 ~ 2015.3
- ȼøÀü³²´ëÇб³º´¿ø Áø·áóÀå
- ¤ý2020.1 ~ ÇöÀç
- ȼø±º¸³¿ä¾çº´¿ø º´¿øÀå
-
-
-
- ´ëÇÑ ¹æ»ç¼±Á¾¾çÇÐȸ Á¤È¸¿ø
- ´ëÇÑ ¾ÏÇÐȸ Á¤È¸¿ø
- ´ëÇÑ ¿µ»óÀÇÇÐȸ Á¤È¸¿ø
- ´ëÇÑ ÀÇÇй°¸®ÇÐȸ ȸ¿ø
- ´ëÇÑ ¹æ»ç¼± ¹æ¾îÇÐȸ Á¤È¸¿ø
- À¯·´ ¹æ»ç¼± Á¾¾çÇÐȸ ±¹Á¦È¸¿ø
- ¹Ì±¹ ¹æ»ç¼±Á¾¾çÇÐȸ ±¹Á¦È¸¿ø
-
-
-
ÇØ¿Ü¿¬¼ö
-
- ¤ý1990.10
- ¹Ì±¹, ¿ÀÇÏÀÌ¿À, Cleveland, Metrohealth Hospital ¿¬¼ö
- ¤ý1995.1 ¡ 1996.1
- ¹Ì±¹, Åػ罺´ë. M.D. Anderson Cancer Center ¿¬¼ö
- ¤ý2004.4
- ¹Ì±¹, ´º¿å, ½Ã¶óÅ¥½º, Upstate Medical University Hospital ¿¬¼ö
-
-
-
¸éÇã ¹× ÀÚ°ÝÁõ
-
- ¤ý1979.2
- ÀÇ»ç¸éÇã
- ¤ý1983.4
- Áø´Ü ¹× Ä¡·á¹æ»ç¼±°úÀü¹®ÀÇ Ãëµæ
- ¤ý1986.1
- ¹æ»ç¼ºµ¿À§¿ø¼ÒÃë±ÞÀÚ Æ¯¼ö¸éÇãÃëµæ
- ¤ý1991
- ÀÇÇйڻç ÇÐÀ§ Ãëµæ
-
-
-
- ¤ý2003.9.26
- ¹ýÀÎÈ 10³â ±Ù¼Ó, Àü³²´ëº´¿øÀå ǥâ(Á¦827È£)
- ¤ý2003.9.26
- Àü³²´ëº´¿øÀå ǥâ(Á¦1553È£)
- ¤ý2006.9.26
- Àü³²´ëº´¿øÀå ǥâ(Á¦2075È£)
- ¤ý2010.6.28
- 20³â ±Ù¼Ó Àü³²´ë ÃÑÀå ǥâ(Á¦10295È£)
-
-
-
ÃÖ±Ù ¿¬±¸ ¾÷Àû
-
- 1. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12)
(BREAST 2019; 49(1):41-47)
- 2. Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
(Radiation oncology journal. 2019. 37(3); 215-223)
- 3. Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study.
(Radiotherapy Oncology. 2018. 129(2);347-351)
- 4. p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma.
(Oncolgy Letters. 2018. 15(5);6571-6577)
- 5. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
(European Journal of Nuclear Medicine and Molecular Imaging. 2018. 45(2);170-178)
- 6. Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.
(Japanese Journal Of Clinical Oncology. 2018. 48(2); 144-152)
- 7. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells.
(Cytotherapy. 2018. 20(5);715-727)
-
-